Weight-loss drug developer Kailera Therapeutics' shares surged 62.5% in their Nasdaq debut on Friday after closing a $625 ...
By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1. Purpose and ...
With shortages of medical professionals and an aging population, thousands of community health care workers prevent older ...
At a moment when there's a lot of political attention around questions of affordability, rising health care costs are a ...
Louisiana lawmakers debated a bill that would require Medicaid to cover FDA-approved weight-loss medications for its ...
The trading gives Waltham-based Kailera a market value of almost $3.1 billion based on the outstanding shares listed in its ...
With obesity rates among the highest in the nation, lawmakers are considering whether Medicaid should cover weight-loss ...
The GLP-1 weight loss drugs revolutionizing the treatment of obesity, diabetes and a slew of other diseases come with a major ...
Future doctors are learning to prepare healthy, flavorful meals and turn nutrition advice into patient guidance in new ...
A group of global experts is proposing a new way to define and diagnose obesity, reducing the emphasis on the controversial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results